PTAB

IPR2017-01526

Mylan Pharmaceuticals Inc v. Sanofi Aventis Deutschland GmbH

General
Filed
06/05/17
Institution12/13/17
FWD--
Close12/12/18
StatusFinal Written Decision
OutcomeUnpatentable
USPTOIPR2017-01526
Appeals19-1368
Administrative Patent Judges
Judge
Cases
Inst. Rate
FWD Inv. Rate
Erica A Franklin
400+
56%
69%
Michelle N Ankenbrand
200+
50%
81%
Roberta Pollock
400+
70%
71%
Respondent
Party
Attorney